PTC Announces Expansion of Translarna Label to Include Ambulatory Patients as Young as 2 Years Old…
PTC Therapeutics, Inc. announced that the Brazilian National Health Surveillance Agency, ANVISA (Agência Nacional de Vigilância Sanitária), has approved the expansion of the indication…
Read More...
Read More...